Inter-observer variability in the measurement of diffuse intrinsic pontine gliomas.
Diffuse intrinsic pontine glioma (DIPG) is an invasive pediatric brainstem tumor with a poor prognosis. Patients commonly enter investigational trials, many of which use radiographic response as an endpoint for assessing drug efficacy. However, DIPGs are difficult to measure on magnetic resonance imaging (MRI). In this study, we characterized the reproducibility of these commonly performed measurements. Each of four readers measured 50 MRI scans from DIPG patients and inter-observer variability was estimated with descriptive statistics. Results confirmed that there is wide variability in DIPG tumor measurements between readers for all image types. Measurements on FLAIR imaging were most consistent. For patients on clinical trials, measurement of DIPG should be performed by a single reader while comparing prior images side-by-side. Endpoints for clinical trials determining efficacy in this population should also include more objective measures, such as survival, and additional endpoints need to be investigated.
Hayward
Robert M
RM
Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10 CRC, Rm 1-3940, Bethesda, MD 20892, USA.
Patronas
Nicolas
N
Baker
Eva H
EH
Vézina
Gilbert
G
Albert
Paul S
PS
Warren
Katherine E
KE
D020295:Brain Stem Neoplasms / Q000453:epidemiology* / Q000473:pathology*; D002648:Child; D002675:Child, Preschool; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D005910:Glioma / Q000453:epidemiology* / Q000473:pathology*; D006801:Humans; D007223:Infant; D008279:Magnetic Resonance Imaging; D008297:Male; D015588:Observer Variation